7546-66-9Relevant academic research and scientific papers
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron, Lindsay P.,Tombari, Robert J.,Lu, Ju,Pell, Alexander J.,Hurley, Zefan Q.,Ehinger, Yann,Vargas, Maxemiliano V.,McCarroll, Matthew N.,Taylor, Jack C.,Myers-Turnbull, Douglas,Liu, Taohui,Yaghoobi, Bianca,Laskowski, Lauren J.,Anderson, Emilie I.,Zhang, Guoliang,Viswanathan, Jayashri,Brown, Brandon M.,Tjia, Michelle,Dunlap, Lee E.,Rabow, Zachary T.,Fiehn, Oliver,Wulff, Heike,McCorvy, John D.,Lein, Pamela J.,Kokel, David,Ron, Dorit,Peters, Jamie,Zuo, Yi,Olson, David E.
, p. 474 - 479 (2021)
The psychedelic alkaloid ibogaine has anti-addictive properties in both humans and animals1. Unlike most medications for the treatment of substance use disorders, anecdotal reports suggest that ibogaine has the potential to treat addiction to v
AZEPINO-INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS
-
Paragraph 0215-0216, (2020/09/12)
The present invention provides azepino-indoles and other heterocycles and methods of using the compounds for treating brain disorders.
Practical syntheses of hexahydroazepino[4,5-b]- and hexahydroazocino[4,5-b]indoles
Diker, Khalid,De Maindreville, Michele Doee,Levy, Jean
, p. 3511 - 3512 (2007/10/02)
Catalytic hydrogenation (Pd·C) of 2-(2-benzylaminoethyl)-3-cyanomethyl indoles gave hexahydroazepino[4,5-b]indoles in good yields. 2-(2-Benzylaminoethyl)-3 cyanoethyl indoles were cyclized to hexahydroazocino[4,5-b]indoles under identical conditions.
